Please provide your email address to receive an email when new articles are posted on . Mitral annulus calcification may be an independent risk factor for all-cause mortality and was more common among ...

Dr. Paul Sorajja at Banner – University Medical Center Phoenix has pioneered a groundbreaking treatment for severe mitral ...

Patients with mitral annulus calcification are at more than double the risk for mitral valve dysfunction, a study published June 1 in Mayo Clinic Proceedings found. Researchers retrospectively ...

PARIS--(BUSINESS WIRE)--HighLife SAS, a medtech company focused on the development of a novel Trans-Septal Mitral Valve Replacement (“TSMVR”) system to treat patients suffering from moderate to severe ...

People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the aorta, who underwent transcatheter aortic valve replacement (TAVR) with a supra-annular ...

HighLife plans to prioritise procedural consistency and imaging-guided follow-up for safety in early commercial settings.

Ideal Navitor Implant Depth for Redo-TAVR Feasibility and Coronary Re-Access: CT- Simulation Study Receive the the latest news, research, and presentations from major meetings right to your inbox.

SAN FRANCISCO -- One anatomic feature, typically found in women, did not make patients with severe aortic stenosis (AS) better suited for either transcatheter aortic valve replacement (TAVR) or ...

CHICAGO, IL—Patients undergoing TAVR with a self-expanding supra-annular bioprothesis (CoreValve, Evolut R, or Evolut PRO; Medtronic) have lower aortic valve mean pressure gradients, larger effective ...